Rebecca Jensen

Lecturer

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rebecca Jensen is a Lecturer at the University of Liverpool, UK. Her research primarily focuses on pharmacokinetics, immune responses to viral infections, and COVID-19 dynamics. She has contributed to various studies investigating the safety and efficacy of antiretroviral therapies, the impact of viral mutations on T cell recognition, and hospital management during the COVID-19 pandemic.

Articles (10)

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (26)

Laurence McEvoy

University of Liverpool

UNITED KINGDOM

Rebecca Jensen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic review

Glycolysis: An early marker for vancomycin‐specific T‐cell activation

Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1

A prenylated dsRNA sensor protects against severe COVID-19

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.

Collaborators (26)

Laurence McEvoy

Luke Hodgson

Professor Marta García-Fiñana

Eddie Wang

Kenneth A McLean

Kyriaki Nomikou

Jeffrey Y. Lee

Ruth Jarrett

Petros Andrikopoulos

Neill Liptrott

Christian Julian Villabona Arenas

Matthew Krantz

Joseph Hughes

Matthew Turnbull

Amy Chadwick

Rute Maria Pinto

Vanessa Herder

Matthew O'Shea

Dr Benjamin Lindsey

Ilan Davis

Angie Fawkes

Deborah Lavin

Quentin Leclerc

Marko Noerenberg

Mark Peters

Margus Varjak

Make your next move.